1 – 10 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Sequence enrichment profiles enable target-agnostic antibody generation for a broad range of antigens
(
- Contribution to journal › Article
- 2021
-
Mark
Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
(
- Contribution to journal › Article
- 2019
-
Mark
Deep mining of complex antibody phage pools generated by cell panning enables discovery of rare antibodies binding new targets and epitopes
(
- Contribution to journal › Article
- 2018
-
Mark
Antibodies to Costimulatory Receptor 4-1BB Enhance Anti-tumor Immunity via T Regulatory Cell Depletion and Promotion of CD8 T Cell Effector Function
(
- Contribution to journal › Article
- 2017
-
Mark
A single-arm, open-label, phase 2 clinical trial evaluating disease response following treatment with BI-505, a human anti-intercellular adhesion molecule-1 monoclonal antibody, in patients with smoldering multiple myeloma
(
- Contribution to journal › Article
- 2015
-
Mark
A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma.
(
- Contribution to journal › Article
-
Mark
Antagonistic Human FcγRIIB (CD32B) Antibodies Have Anti-Tumor Activity and Overcome Resistance to Antibody Therapy In Vivo.
(
- Contribution to journal › Article
- 2013
-
Mark
A human icam-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo.
(
- Contribution to journal › Article
- 2008
-
Mark
Design of recombinant antibody microarrays for cell surface membrane proteomics
(
- Contribution to journal › Article
- 2007
-
Mark
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.
(
- Contribution to journal › Article